eAMS-Eco: Implementation of a Tool for Climate Conscious Inhaler Prescribing (NCT07638735) | Clinical Trial Compass
By InvitationNot Applicable
eAMS-Eco: Implementation of a Tool for Climate Conscious Inhaler Prescribing
Canada95 participantsStarted 2026-04-28
Plain-language summary
The goal of this study is to determine whether an 'eco' version of the Electronic Asthma Management System (eAMS) can reduce inhaler carbon emissions in primary care, in patients with asthma. The existing eAMS uses patient-specific criteria (asthma control, asthma flare-up risk, and current medications) to provide guideline-based computerized clinical decision support to clinicians, to improve the delivery of asthma care. The eAMS-Eco includes embedded cues and messaging on the environmental impact of inhaler medications and links to a patient-friendly conversation aid that facilitates shared decision-making and climate-conscious prescribing.
The study will evaluate the implementation of the eAMS-Eco in four primary care clinics that have been using the existing eAMS, using an interrupted time-series analysis (one year pre- and post-launch of the eAMS-Eco). The investigators will assess system uptake and user feedback on the eAMS-Eco, as well as changes in inhaler prescriptions (including resulting changes in carbon emissions and costs) and changes in asthma control, in the implementation period (eAMS-Eco) compared to the baseline period (eAMS).
Who can participate
Age range
16 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
Active clinician at one of the four study sites during the study period
. asthma billing code (493) in the past 3 years OR asthma in the cumulative patient profile (CPP) and
. prescription for an inhaler in the past year
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial seems focused on reducing the carbon footprint of inhalers rather than testing a new medication — can you help me understand whether joining would change which inhaler I'm actually prescribed, and how that might affect how well my asthma is controlled?
2Since this study is measuring the ratio of low-carbon to high-carbon inhalers prescribed, does that mean there could be pressure to switch me to a different inhaler type even if my current one is working well for me?
3This trial is enrolling by invitation only — am I actually being considered for it, and if so, what does participation involve on my end as a patient versus just changes your practice might make in how you prescribe?
4Dry powder inhalers tend to have a lower carbon footprint than pressurised metered-dose inhalers — if this study might lead to switching inhaler types, how would you and I decide together whether a different device is a good fit for my breathing technique and lifestyle?
5Are there any situations where staying on my current inhaler would be the right call regardless of what this tool recommends, and how would that decision be made?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Prescribed inhaler carbon emissions
Timeframe: 24 months, cumulative and broken into individual time periods
2
Proportion of low carbon footprint inhalers to moderate/high carbon footprint inhalers prescribed
Timeframe: 24 months, cumulative and broken into individual time periods